Dianthus Therapeutics (DNTH) Profit After Tax (2017 - 2025)
Dianthus Therapeutics' (DNTH) quarterly Profit After Tax came in at $65000.0 in Q3 2025, up 100.27% year-on-year from $32456.9 in Q3 2024, and up 100.21% quarter-over-quarter from -$31.6 million in Q2 2025.
Dianthus Therapeutics (DNTH) Profit After Tax (2017 - 2025) Analysis & Trends
Dianthus Therapeutics' Profit After Tax history runs 9 years deep, the most recent figure standing at $65000.0 for Q3 2025.
- On a quarterly basis, Profit After Tax rose 100.27% year-over-year to $65000.0 in Q3 2025; TTM through Sep 2025 was -$5.0 million, a 92.54% increase from a year earlier, with the FY2024 full-year figure at $59000.0, up 100.14% from the prior year.
- Profit After Tax improved to $65000.0 in Q3 2025 per DNTH's latest filing, from -$31.6 million in the prior quarter.
- Across five years, Profit After Tax topped out at $56.0 million in Q4 2024 and bottomed at -$31.6 million in Q2 2025.
- The 5-year median for Profit After Tax is -$13.7 million (2024), against an average of -$8.0 million.
- Across the five-year window, Profit After Tax jumped 83708.06% in 2021 and sank 154.69% in 2022, its largest moves.
- Year by year, Profit After Tax stood at $51.8 million in 2021, then sank by 154.69% to -$28.4 million in 2022, then jumped by 62.61% to -$10.6 million in 2023, then surged by 627.87% to $56.0 million in 2024, then sank by 99.88% to $65000.0 in 2025.
- Per Business Quant, the three latest DNTH Profit After Tax figures stand at $65000.0 (Q3 2025), -$31.6 million (Q2 2025), and -$29.3 million (Q1 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -36.84 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 227.36 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.03 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -65.60 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | -26.94 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 362.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -453.82 Mn |
| 10 | Dianthus Therapeutics | 3.37 Bn | 2.97 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 65,000.00 |
| Jun 30, 2025 | -31.63 Mn |
| Mar 31, 2025 | -29.35 Mn |
| Dec 31, 2024 | 55.95 Mn |
| Sep 30, 2024 | -24.46 Mn |
| Jun 30, 2024 | -17.61 Mn |
| Mar 31, 2024 | -13.75 Mn |
| Dec 31, 2023 | -10.60 Mn |
| Sep 30, 2023 | -14.75 Mn |
| Jun 30, 2023 | -11.14 Mn |
| Mar 31, 2023 | -7.09 Mn |
| Dec 31, 2022 | -28.35 Mn |
| Sep 30, 2022 | -7.93 Mn |
| Jun 30, 2022 | -5.70 Mn |
| Mar 31, 2022 | -4.88 Mn |
| Dec 31, 2021 | 51.84 Mn |
| Sep 30, 2021 | -17.43 Mn |
| Jun 30, 2021 | -16.94 Mn |
| Mar 31, 2021 | -17.46 Mn |
| Dec 31, 2020 | -62,000.00 |